The effect of CTAB concentration in cationic PLG microparticles on DNA adsorption and in vivo performance

被引:43
作者
Singh, M [1 ]
Ugozzoli, M [1 ]
Briones, M [1 ]
Kazzaz, J [1 ]
Soenawan, E [1 ]
O'Hagan, DT [1 ]
机构
[1] Chiron Corp, Immunol & Infect Dis, Emeryville, CA 94608 USA
关键词
CTAB; cationic microparticles; PLG (polylactide-co-lycolide); DNA delivery; adjuvant; vaccines;
D O I
10.1023/A:1022327305369
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Cationic PLG microparticles with adsorbed DNA have previously been shown to efficiently target antigen presenting cells in vivo for generating higher immune responses in comparison to naked DNA. In this study we tried to establish the role of surfactant (CTAB) concentration on the physical behavior of these formulations. Methods. Cationic PLG microparticle formulations with adsorbed DNA were prepared using a solvent evaporation technique. Formulations with varying CTAB concentrations and a fixed DNA load were prepared. The loading efficiency and 24 h DNA release was evaluated for each formulation. Select formulations were tested in vivo. Results. Higher CTAB concentration correlated with higher DNA binding efficiency on the microparticles and lower in vitro release rates. Surprisingly though, the in vivo performance of formulations with varying CTAB concentration was comparable to one another. Conclusions. Cationic PLG microparticles with adsorbed DNA, as described here, offer a robust way of enhancing in vivo responses to plasmid DNA.
引用
收藏
页码:247 / 251
页数:5
相关论文
共 22 条
  • [1] PLGA microspheres containing plasmid DNA: Preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization
    Ando, S
    Putnam, D
    Pack, DW
    Langer, R
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (01) : 126 - 130
  • [2] The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery
    Briones, M
    Singh, M
    Ugozzoli, M
    Kazzaz, J
    Klakamp, S
    Ott, G
    O'Hagan, D
    [J]. PHARMACEUTICAL RESEARCH, 2001, 18 (05) : 709 - 712
  • [3] Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA
    Capan, Y
    Woo, BH
    Gebrekidan, S
    Ahmed, S
    DeLuca, PP
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (04) : 509 - 513
  • [4] Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells
    Denis-Mize, KS
    Dupuis, M
    MacKichan, ML
    Singh, M
    Doe, B
    O'Hagan, D
    Ulmer, JB
    Donnelly, JJ
    McDonald, DM
    Ott, G
    [J]. GENE THERAPY, 2000, 7 (24) : 2105 - 2112
  • [5] DNA vaccines
    Donnelly, JJ
    Ulmer, JB
    Liu, MA
    [J]. LIFE SCIENCES, 1996, 60 (03) : 163 - 172
  • [6] DNA vaccines: Immunology, application, and optimization
    Gurunathan, S
    Klinman, DM
    Seder, RA
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 927 - 974
  • [7] Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses
    Hedley, ML
    Curley, J
    Urban, R
    [J]. NATURE MEDICINE, 1998, 4 (03) : 365 - 368
  • [8] Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration
    Jones, DH
    Corris, S
    McDonald, S
    Clegg, JCS
    Farrar, GH
    [J]. VACCINE, 1997, 15 (08) : 814 - 817
  • [9] Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1
    Kazzaz, J
    Neidleman, J
    Singh, M
    Ott, G
    O'Hagan, DT
    [J]. JOURNAL OF CONTROLLED RELEASE, 2000, 67 (2-3) : 347 - 356
  • [10] Lemieux Pierre, 2002, Expert Rev Vaccines, V1, P85, DOI 10.1586/14760584.1.1.85